Ilyang Pharmaceutical Co Ltd (007575.KS)
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.
Company Info
Highlights
₩329.98B
₩252.35B
₩97.62B
₩9,309.88 - ₩14,990.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Ilyang Pharmaceutical Co Ltd (007575.KS) returned 25.72% year-to-date (YTD) and -9.08% over the past 12 months. Over the past 10 years, 007575.KS returned -5.31% annually, underperforming the S&P 500 benchmark at 10.85%.
007575.KS
25.72%
6.44%
28.50%
-9.08%
-29.43%
-15.38%
-5.31%
^GSPC (Benchmark)
0.51%
3.96%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 007575.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.96% | 9.26% | -10.57% | 19.43% | 6.70% | 25.72% | |||||||
| 2024 | -8.22% | -1.84% | 8.72% | -5.80% | -4.33% | -6.37% | -8.85% | 1.52% | -3.72% | -3.61% | -12.01% | 2.21% | -36.16% |
| 2023 | -1.42% | 0.96% | -11.71% | 1.94% | 0.90% | -6.82% | -15.81% | 1.47% | 5.40% | -9.69% | 16.82% | -0.94% | -20.75% |
| 2022 | -14.78% | 3.67% | 14.76% | -4.97% | 38.99% | -34.55% | 4.76% | -5.68% | -19.68% | 0.75% | 3.23% | 2.27% | -26.01% |
| 2021 | -24.37% | 3.31% | -50.08% | 21.31% | 2.91% | -0.51% | -12.77% | -0.30% | -5.93% | -6.31% | -13.13% | 12.33% | -63.77% |
| 2020 | -0.87% | -1.17% | 31.56% | -15.47% | 67.11% | 185.71% | 16.67% | -13.05% | 16.65% | -21.60% | -16.89% | 15.50% | 363.34% |
| 2019 | 8.99% | -4.00% | 3.39% | 16.37% | -12.77% | -1.74% | -12.63% | -4.05% | 0.00% | 3.92% | -3.77% | 5.08% | -4.94% |
| 2018 | 4.10% | -5.25% | -0.40% | -2.98% | 6.35% | -13.68% | -0.67% | 3.37% | 0.65% | -21.81% | 13.54% | -10.71% | -28.32% |
| 2017 | -5.56% | 4.83% | -5.01% | 0.21% | 21.89% | -10.02% | -9.21% | 6.34% | -5.17% | -2.73% | 12.07% | -1.54% | 1.59% |
| 2016 | 19.27% | -14.25% | -11.72% | -2.18% | -2.41% | 14.79% | -10.28% | -1.71% | 3.65% | -20.81% | -3.39% | 11.08% | -23.14% |
| 2015 | 12.46% | 7.00% | 8.17% | -4.28% | 24.47% | 98.73% | -15.11% | -13.03% | 13.69% | -2.41% | -1.17% | -13.40% | 116.07% |
| 2014 | -1.56% | 10.79% | -4.74% | 1.82% | -0.30% | -3.58% | -4.02% | -0.97% | 2.93% | 0.32% | -1.58% | -2.24% | -3.97% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 007575.KS is 33, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Ilyang Pharmaceutical Co Ltd (007575.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Ilyang Pharmaceutical Co Ltd provided a 1.34% dividend yield over the last twelve months, with an annual payout of ₩175.00 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₩175.00 | ₩175.00 | ₩175.00 | ₩175.00 | ₩225.00 | ₩145.00 | ₩145.00 | ₩0.00 | ₩0.00 | ₩125.00 | ₩0.00 | ₩125.00 |
Dividend yield | 1.34% | 1.69% | 1.06% | 0.83% | 0.78% | 0.18% | 0.84% | 0.00% | 0.00% | 0.50% | 0.00% | 0.82% |
Monthly Dividends
The table displays the monthly dividend distributions for Ilyang Pharmaceutical Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |||||||
| 2024 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩175.00 | ₩175.00 |
| 2023 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩175.00 | ₩175.00 |
| 2022 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩175.00 | ₩175.00 |
| 2021 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩225.00 | ₩225.00 |
| 2020 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩145.00 | ₩145.00 |
| 2019 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩145.00 | ₩145.00 |
| 2018 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2017 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2016 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩125.00 | ₩125.00 |
| 2015 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2014 | ₩125.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩125.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Ilyang Pharmaceutical Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ilyang Pharmaceutical Co Ltd was 93.09%, occurring on Dec 9, 2024. The portfolio has not yet recovered.
The current Ilyang Pharmaceutical Co Ltd drawdown is 90.54%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.09% | Jun 22, 2020 | 1099 | Dec 9, 2024 | — | — | — |
| -90.83% | Aug 13, 2007 | 282 | Oct 28, 2008 | 1647 | Jun 26, 2015 | 1929 |
| -87.26% | Dec 5, 1995 | 573 | Sep 25, 1998 | 201 | Aug 13, 1999 | 774 |
| -86.25% | Sep 3, 1999 | 1119 | May 17, 2004 | 323 | Sep 13, 2005 | 1442 |
| -77.46% | Jul 7, 2015 | 1001 | Aug 5, 2019 | 208 | Jun 10, 2020 | 1209 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Ilyang Pharmaceutical Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Ilyang Pharmaceutical Co Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 007575.KS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 007575.KS has a P/S ratio of 1.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 007575.KS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 007575.KS has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |